Jay Achar

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

James A. Seddon

UNITED KINGDOM

View details

Masoud Dara

Honorary Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

View details

Nicolas Paul

GERMANY

View details

Stefan Kohler

Heidelberg University

GERMANY

View details

Anthony Garcia-Prats

Associate Professor

University of Wisconsin School of Medicine and Public Health

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jay Achar

Research Interests

Explore related searches

Contact this professor

Articles (20)

Detection of aerosolized Mycobacterium tuberculosis DNA from adults being investigated for pulmonary tuberculosis using an electrostatic sampler in a South African primary care setting

Waste to worth: diagnostic accuracy of Xpert MTB/XDR on contaminated liquid cultures to salvage the detection of drug-resistant tuberculosis

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis

Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis

Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study

A 10-year review of isoniazid-resistant TB management in Uzbekistan 2009-2020

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024

Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region

Costs and import costs of past, present, and future TB drug regimens: a case study for Karakalpakstan, Uzbekistan

Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing

Household drug-resistant TB contact tracing in Tajikistan

Global impact of COVID-19 on childhood tuberculosis: an analysis of notification data

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan

Treatment of Rifampicin-Resistant Tuberculosis Disease and Infection in Children: Key Updates, Challenges and Opportunities

Programme costs of longer and shorter tuberculosis drug regimens and drug import: a modelling study for Karakalpakstan, Uzbekistan

Factors associated with culture conversion among adults treated for pulmonary extensively drug-resistant tuberculosis during 2018-2019 in the Russian Federation: an observational cohort study

Factors associated with time to sputum culture conversion of rifampicin-resistant tuberculosis patients in Klaipeda, Lithuania in 2016-2019: a cohort study

Accuracy of molecular drug susceptibility testing amongst tuberculosis patients in Karakalpakstan, Uzbekistan.

Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan

Collaborators (5)

James A. Seddon

Masoud Dara

Nicolas Paul

Stefan Kohler

Anthony Garcia-Prats

Make your next move.